US FDA Layoffs Hit Conflict-Of-Interest Screening For ODAC Meeting

 
• By Sue Sutter and Derrick Gingery

Screening for conflicts and finding the right expertise for a two-day Oncologic Drugs Advisory Committee meeting on four products has been complicated by the Trump Administration’s initial communications freeze and subsequent layoffs in CDER.

Segmenting pawns
Screening potential advisory committee members for product-specific meetings is a labor-intensive, time-consuming process. (Shutterstock)

More from US Advisory Committees

More from Product Reviews